Straight answers on GLP-1s

Which shot is actually right for you?

We compare GLP-1 medications and the licensed telehealth providers that prescribe them — plainly, with sources, and without the sales pitch.

Ozempic
semaglutide
Approved forType 2 diabetes
DosingWeekly
FormInjection
See full profile →
Wegovy
semaglutide
Approved forWeight management
DosingWeekly
FormInjection
See full profile →
Mounjaro
tirzepatide
Approved forType 2 diabetes
DosingWeekly
FormInjection
See full profile →
Zepbound
tirzepatide
Approved forWeight management
DosingWeekly
FormInjection
See full profile →
Licensed providers

Where to actually get prescribed

Every provider below employs licensed clinicians who evaluate you before prescribing anything. We compare them the same way we compare the medications: plainly.

Ro
Editor's pick
Starting price$[verify]/mo
Medications offeredSemaglutide, tirzepatide
InsuranceAccepted where eligible
Get started with Ro →

Placeholder pricing — replace with current, verified figures and your live affiliate link before publishing.

Found
Starting price$[verify]/mo
Medications offeredSemaglutide, tirzepatide
InsuranceAccepted where eligible
Get started with Found →

Placeholder pricing — replace with current, verified figures and your live affiliate link before publishing.

Sequence
Starting price$[verify]/mo
Medications offeredSemaglutide, tirzepatide
InsuranceAccepted where eligible
Get started with Sequence →

Placeholder pricing — replace with current, verified figures and your live affiliate link before publishing.

Reviewed by people who actually treat this.

Every clinical claim on DosageBuzz is checked by a licensed medical reviewer before it goes live. We earn commissions when you sign up through a provider we link to — that never changes what we say about them.

M Medically reviewed content
E Editorially independent ratings
S Sourced from FDA & peer-reviewed data
Stay current

New comparisons and pricing updates, when they happen

GLP-1 pricing and coverage shift often. We'll email you when we publish a new comparison or a real pricing change — nothing else.